OpenAlex
PricingAboutJobs
Log inGet started
Work

The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept

HTML

Year: 2010
Type: article
Study design: Observational Study
Source: Annals of the Rheumatic Diseases
DOI: 10.1136/ard.2010.135111
Authors: Anna Jamnitski, Geertje M Bartelds, Michael T Nurmohamed, Pauline A van Schouwenburg, Dirkjan van Schaardenburg, Steven O Stapel, Ben A C Dijkmans, Lucien Aarden, Gerrit Jan Wolbink
Institutions: Amsterdam UMC Location Vrije Universiteit Amsterdam, Sanquin
Language: English

Topic: Rheumatoid Arthritis Research and Therapies
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: rheumatoid arthritis, TNF-alpha inhibitors, etanercept, infliximab, adalimumab, anti-drug antibodies, immunogenicity, treatment response, DAS28, personalized treatment
SDG: Good health and well-being

Open Access status: closed

Funders: Arthritis Foundation, Dutch Arthritis Association
OpenAlex ID: W2123170396
FWCI: 9.238
Cites: 29
Cited by: 193
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms